GB201210328D0 - Biomarker - Google Patents
BiomarkerInfo
- Publication number
- GB201210328D0 GB201210328D0 GB201210328A GB201210328A GB201210328D0 GB 201210328 D0 GB201210328 D0 GB 201210328D0 GB 201210328 A GB201210328 A GB 201210328A GB 201210328 A GB201210328 A GB 201210328A GB 201210328 D0 GB201210328 D0 GB 201210328D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- patient
- methods
- relates
- tnf
- symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201210328A GB201210328D0 (en) | 2012-06-12 | 2012-06-12 | Biomarker |
PCT/GB2013/051518 WO2013186541A1 (fr) | 2012-06-12 | 2013-06-10 | Biomarqueur pour la détermination de la compatibilité d'une thérapie anti-facteur de nécrose tumorale (anti-tnf) dans le traitement de maladies auto-immunes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201210328A GB201210328D0 (en) | 2012-06-12 | 2012-06-12 | Biomarker |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201210328D0 true GB201210328D0 (en) | 2012-07-25 |
Family
ID=46605772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201210328A Ceased GB201210328D0 (en) | 2012-06-12 | 2012-06-12 | Biomarker |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201210328D0 (fr) |
WO (1) | WO2013186541A1 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005072340A2 (fr) * | 2004-01-27 | 2005-08-11 | Compugen Ltd. | Nouveaux polynucleotides codant pour des polypeptides et leurs procedes d'utilisation |
US7785834B2 (en) * | 2005-11-10 | 2010-08-31 | Ercole Biotech, Inc. | Soluble TNF receptors and their use in treatment of disease |
AU2007272824B2 (en) * | 2006-07-13 | 2013-08-01 | Life Technologies Corporation | Gene expression profiling for identification, monitoring and treatment of multiple sclerosis |
WO2008093323A2 (fr) * | 2007-01-29 | 2008-08-07 | Compugen Ltd. | Nucléotide et séquences d'acides aminés atypiques, et leurs procédés d'utilisation dans un diagnostic |
-
2012
- 2012-06-12 GB GB201210328A patent/GB201210328D0/en not_active Ceased
-
2013
- 2013-06-10 WO PCT/GB2013/051518 patent/WO2013186541A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013186541A1 (fr) | 2013-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2013000412A1 (en) | Bcma-based stratification and therapy for multiple myeloma patients | |
MX2022006075A (es) | Antagonistas de union a pd-l1 y usos de los mismos para el tratamiento de cancer. | |
MX2013008833A (es) | Metodos y composiciones relacionadas con la inhibicion de receptor del factor de crecimiento similar a la insulina 1 (igf-1r). | |
MX2022015821A (es) | Nuevos receptores de celulas t y usos de los mismos. | |
NZ722055A (en) | Fcrn antagonists and methods of use | |
JO3242B1 (ar) | طرق علاج داء السكري بمستضادات dll4 | |
PH12016501406A1 (en) | Interleukin-2-fusion proteins and uses thereof | |
EA201391789A1 (ru) | TNF-АЛЬФА АНТИГЕНСВЯЗЫВАЮЩИЕ БЕЛКИ, ОБЛАДАЮЩИЕ ПОВЫШЕННЫМ СВЯЗЫВАНИЕМ FcRn | |
MX2015016814A (es) | Anticuerpo anti-tweakr y sus usos. | |
PH12017500331A1 (en) | Antigen binding proteins that bind cxcr5 | |
GB201021289D0 (en) | Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer | |
MX353143B (es) | Marcadores biologicos y metodos para pronosticar respuesta a antagonistas de celulas b. | |
MX347972B (es) | Anticuerpos estables y solubles que inhiben el vegf. | |
MX2011012039A (es) | Anticuerpos bloqueadores anti-dkk-1 y sus usos. | |
MX358541B (es) | Metodos para predecir el riesgo de desarrollar hipertension. | |
EA201791984A1 (ru) | Способы уменьшения уровня fc-содержащих агентов в сыворотке с применением fcrn-антагонистов | |
NZ604415A (en) | Anti-il-23 heterodimer specific antibodies | |
EA201590187A1 (ru) | Моноклональные антитела для применения в диагностике и терапии злокачественных опухолей и аутоиммунного заболевания | |
CL2012002081A1 (es) | Anticuerpo humanizado que se une a la cadena alfa del receptor de il-7 humano (cd127); proteina de enlace a antigeno que comprende una o mas regiones determinantes de complementariedad de dicho anticuerpo; molecula de acido nucleico que codifica una anticuerpo o proteina de enalce; vector de expresion, celula huesped recombinante; procedimiento para la produccion de una proteina de enlace a antigeno; procedimiento para tratar enfermedad autoinmune o inflamatoria. | |
EA201400964A1 (ru) | Cx3cr1-связывающие полипептиды | |
EA201690503A1 (ru) | Антитела | |
MX2017004742A (es) | Métodos para la predicción de niveles de farmacos anti-tnf alfa y formación de autoanticuerpos. | |
MX2020010094A (es) | Kir3dl3 como receptor de hhla2, anticuerpos anti-hhla2 y usos de estos. | |
MA39847A (fr) | Protéines de liaison à l'antigène se liant à wisp1 | |
PH12017500332A1 (en) | Antigen binding proteins that bind cxcr3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |